Adam M Green, DO | |
28050 Grand River Ave, Farmington Hills, MI 48336-5919 | |
(248) 615-7265 | |
Not Available |
Full Name | Adam M Green |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 28050 Grand River Ave, Farmington Hills, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346732492 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 1346732492 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Adam M Green, DO 28050 Grand River Ave, Farmington Hills, MI 48336-5919 Ph: (248) 615-7265 | Adam M Green, DO 28050 Grand River Ave, Farmington Hills, MI 48336-5919 Ph: (248) 615-7265 |
News Archive
A study in Italy has identified a dose-response relationship between the concentration of everyday pollutants and the incidence of out-of-hospital cardiac arrest. The research is presented at ESC Congress 2021.
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited has received pricing approval for NESINA® (alogliptin) in Japan. NESINA, a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, received regulatory approval from the Japanese Ministry of Health, Labour and Welfare on April 16, 2010. Furiex collaborated with Takeda to develop this product.
Dr Patricia Kearney, Department of Epidemiology & Public Health, UCC is one of a group of researchers from European Universities who will participate in a new research project investigating current treatment practices for people who suffer from a mildly underactive thyroid gland.
Sunovion Pharmaceuticals Inc. today announced the results of the PEARL 3 study, the third phase 3 worldwide clinical trial of Latuda® (lurasidone HCl) tablets, a once-daily atypical antipsychotic agent recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with schizophrenia. In this six-week, placebo-controlled trial, both fixed doses of LATUDA 80 and 160 mg once-daily, demonstrated statistically significant improvement in symptoms of schizophrenia versus placebo across both primary and secondary efficacy measures.
› Verified 7 days ago
Mr. Stanley Li, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave., Farmington Hills, MI 48336 Phone: 947-521-8000 | |
Dr. Nicholas Runge, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 947-521-8000 | |
William Jeffrey Padget, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 931-247-2365 | |
Brandon Wallace, Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 947-521-7265 | |
Dr. Samuel Rosenbaum, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 32255 Northwestern Hwy Ste 100, Farmington Hills, MI 48334 Phone: 888-647-1100 Fax: 248-419-3544 | |
Dr. Matthew E. Charlick, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 947-521-8000 | |
Dr. Michael Joseph Wilk, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 947-521-8000 |